Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine

被引:10
|
作者
Cassells, NP
Craston, DH
Hand, CW
Baldwin, D
机构
[1] COZART BIOSCI LTD,ABINGDON OX14 4RU,OXON,ENGLAND
[2] LAB GOVT CHEMIST,STRATEG RES UNIT,TEDDINGTON TW11 0LY,MIDDX,ENGLAND
关键词
D O I
10.1093/jat/20.6.409
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A microplate enzyme immunoassay (EIA) for the detection of lysergic acid diethylamide (LSD) in human urine was developed. The assay kit is designed around an LSD derivative coated on the wall of microplate wells with preservatives and stabilizers. Sample and rabbit anti-LSD are added to the microplate well. The immobilized LSD and LSD present in specimens compete for the opportunity to bind to the anti-LSD antibodies. An anti-rabbit antibody labeled with horseradish peroxidase is used to provide the assay signal, which is inversely proportional to the concentration of LSD in the sample. The assay requires a 25-μL urine sample and three consecutive incubation periods of 60, 30, and 30 min at room temperature. The assay was tested with a variety of drugs, including ergot alkaloids spiked into drug-free urine at up to 100,000 ng/mL without cross-reaction. Nor-LSD was shown to cross-react between 16% and 28%, depending on its concentration. Of the other compounds tested, only ergonovine demonstrated slight cross-reactivity at approximately 0.0008%. The assay is designed to be used with a qualitative cutoff of 0.5 ng/mL. Precision testing at 0.5 ng/mL gave a coefficient of variation (CV) of 6% based on 20 replicates. The CV at 0.375 ng/mL (cutoff, -25%) was 5.2% and at 0.625 ng/mL was 6.6%. Precision at other concentrations within the range of the calibration curve gave similar results both intra- and interassay. Clinical performance of the assay was compared with that of a commercial radioimmunoassay (RIA). Comparable performance was observed with both methods, each screening a total of 458 samples as negative and 17 samples as positive relative to a 0.5 ng/mL cutoff. The EIA found an additional three positive samples that were negative by RIA. The EIA is suitable for the screening of urine samples for the presence of LSD. Preliminary indications are that the assay is also suitable for use with whole blood specimens. The assay can be performed manually or be fully automated and without the need for radioactivity; it can be used in any laboratory.
引用
收藏
页码:409 / 415
页数:7
相关论文
共 50 条
  • [31] Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence
    Gandhi, Monica
    Bacchetti, Peter
    Rodrigues, Warren C.
    Spinelli, Matthew
    Koss, Catherine A.
    Drain, Paul K.
    Baeten, Jared M.
    Mugo, Nelly R.
    Ngure, Kenneth
    Benet, Leslie Z.
    Okochi, Hideaki
    Wang, Guohong
    Vincent, Michael
    ECLINICALMEDICINE, 2018, 2-3 : 22 - 28
  • [32] A NONISOTOPIC, ENZYME-IMMUNOASSAY FOR THE DETERMINATION OF HUMAN LUTEINIZING-HORMONE IN SERUM
    ERALIWOODWARD, M
    KRAUTH, GH
    CLINICAL CHEMISTRY, 1987, 33 (06) : 891 - 891
  • [33] One step lateral flow immunoassay for detection of Ecstasy in human urine.
    Tao, J
    DelosSantos, N
    Dou, C
    CLINICAL CHEMISTRY, 2002, 48 (06) : A43 - A44
  • [34] Development of a bead-based immunoassay for detection of triazophos and application validation
    Liang, Chizhou
    Zou, Mingqiang
    Guo, Lianghong
    Gui, Wenjun
    Zhu, Guonian
    FOOD AND AGRICULTURAL IMMUNOLOGY, 2013, 24 (01) : 9 - 20
  • [35] A high SensitivityHomogeneous enzyme immunoassay for the detection of ethyl glucuronide in human urine.
    Anne, L.
    Mitra, S.
    Shenoy, V.
    Ruzicka, R.
    Gines, L.
    Seto, N.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A100 - A100
  • [36] DETECTION OF LYSERGIC-ACID DIETHYLAMIDE (LSD) IN HUMAN URINE - ELIMINATION, SCREENING AND ANALYTICAL CONFIRMATION
    VUDUC, T
    VERNAY, A
    CALANCA, A
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1991, 121 (50) : 1887 - 1890
  • [37] Highly sensitive nonisotopic immunoassay for PACAP-27 using various detection methods
    Ito, K
    Kodama, R
    Goto, T
    Maeda, M
    Tsuji, A
    Arimura, A
    VIP, PACAP, AND RELATED PEPTIDES, 2ND INTERNATIONAL SYMPOSIUM, 1996, 805 : 743 - 748
  • [38] Development and validation of an immunoassay for quantification of NCAM-1 in human plasma
    Guven, Arcan
    Gray, Kayleigh
    Peng, Kuan-Wei
    Klotz, Allison
    Kellogg, Mark D.
    Narain, Niven R.
    Kiebish, Michael A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 197
  • [39] Analytical and physiological validation of an enzyme immunoassay to measure oxytocin in dog, wolf, and human urine samples
    G. Wirobski
    F. S. Schaebs
    F. Range
    S. Marshall-Pescini
    T. Deschner
    Scientific Reports, 11
  • [40] Analytical and physiological validation of an enzyme immunoassay to measure oxytocin in dog, wolf, and human urine samples
    Wirobski, G.
    Schaebs, F. S.
    Range, F.
    Marshall-Pescini, S.
    Deschner, T.
    SCIENTIFIC REPORTS, 2021, 11 (01)